C4 Therapeutics, Inc.
CCCC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662579
No open-market purchases or sales by C4 Therapeutics, Inc. insiders were filed in the last 90 days; 147 institutions reported holding it in 13F filings for Q2 2026, worth $547.6M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in C4 Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 147
- +24 vs. Q1 2026
- Shares held
- 117.6M
- +33.1M (+39.2%) vs. Q1 2026
- Total value
- $547.6M
- +$326.3M (+147.5%) vs. Q1 2026
- New holders
- 51
- 54 more added
- Sold out
- 27
- 27 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CCCC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 147 | $547.6M |
| Q1 2026 | 123 | $221.3M |
| Q4 2025 | 101 | $152.5M |
| Q3 2025 | 97 | $116.6M |
| Q2 2025 | 102 | $78.2M |
| Q1 2025 | 115 | $102.6M |
| Q4 2024 | 113 | $231.8M |
| Q3 2024 | 118 | $365.9M |
| Q2 2024 | 115 | $281.3M |
| Q1 2024 | 106 | $475.6M |
| Q4 2023 | 92 | $265.6M |
| Q3 2023 | 84 | $64.5M |
| Q2 2023 | 100 | $94.1M |
| Q1 2023 | 121 | $117.5M |
| Q4 2022 | 117 | $231.4M |
| Q3 2022 | 114 | $345.9M |
| Q2 2022 | 113 | $297.2M |
| Q1 2022 | 125 | $904.8M |
| Q4 2021 | 119 | $1.15B |
| Q3 2021 | 113 | $1.54B |
| Q2 2021 | 107 | $1.21B |
| Q1 2021 | 83 | $926.8M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding C4 Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Susquehanna Portfolio Strategies, LLC | 335,079 | $1.56M | 0.02% | +74,800+28.7% | Added |
| Atom Investors LP | 364,351 | $1.70M | 0.15% | +228,304+167.8% | Added |
| Qube Research & Technologies Ltd | 370,554 | $1.73M | 0.00% | −381,560−50.7% | Reduced |
| Seven Fleet Capital Management LP | 381,169 | $1.78M | 0.29% | +324,093+567.8% | Added |
| Platinum Investment Management Ltd | 384,766 | $1.80M | 0.44% | 00.0% | Unchanged |
| Man Group plc | 408,648 | $1.91M | 0.00% | +152,180+59.3% | Added |
| Wells Fargo & Company | 452,701 | $2.11M | 0.00% | −415,210−47.8% | Reduced |
| Nuveen, LLC | 484,010 | $2.26M | 0.00% | +484,010 | New |
| Rockefeller Capital Management L.P. | 495,817 | $2.32M | 0.00% | +495,817 | New |
| StemPoint Capital LP | 523,648 | $2.45M | 0.42% | +70,412+15.5% | Added |
| Velan Capital Investment Management LP | 570,000 | $2.66M | 1.63% | +570,000 | New |
| ExodusPoint Capital Management, LP | 580,195 | $2.71M | 0.03% | +532,688+1,121.3% | Added |
| Vanguard Fiduciary Trust Co | 609,146 | $2.84M | 0.00% | +125,015+25.8% | Added |
| Vanguard Portfolio Management LLC | 680,094 | $3.18M | 0.00% | +680,094 | New |
| Boothbay Fund Management, LLC | 736,331 | $3.44M | 0.07% | +736,331 | New |
| Charles Schwab Investment Management Inc | 781,060 | $3.65M | 0.00% | +328,832+72.7% | Added |
| UBS Group AG | 828,970 | $3.87M | 0.00% | +613,093+284.0% | Added |
| FMR LLC | 894,054 | $4.18M | 0.00% | +621,686+228.3% | Added |
| Congress Asset Management Co | 1,003,437 | $4.69M | 0.03% | +172,813+20.8% | Added |
| Northern Trust Corp | 1,160,547 | $5.42M | 0.00% | +971,068+512.5% | Added |
| Dimensional Fund Advisors LP | 1,188,507 | $5.55M | 0.00% | +745,989+168.6% | Added |
| Renaissance Technologies LLC | 1,189,828 | $5.56M | 0.01% | −1,271,987−51.7% | Reduced |
| HighVista Strategies LLC | 1,348,136 | $6.30M | 1.44% | +1,348,136 | New |
| Patient Square Capital LP | 1,608,815 | $7.51M | 1.16% | +1,608,815 | New |
| Susquehanna International Group, LLP | 1,732,210 | $8.09M | 0.01% | +445,370+34.6% | Added |
| D. E. Shaw & Co., Inc. | 1,740,989 | $8.13M | 0.01% | +680,658+64.2% | Added |
| Candriam Luxembourg S.C.A. | 1,796,937 | $8.38M | 0.04% | +1,796,937 | New |
| Acadian Asset Management LLC | 1,806,199 | $8.43M | 0.01% | −84,715−4.5% | Reduced |
| State Street Corp | 2,115,621 | $9.88M | 0.00% | +1,732,648+452.4% | Added |
| Ikarian Capital, LLC | 2,433,000 | $11.4M | 1.86% | +2,433,000 | New |
| Geode Capital Management, LLC | 2,522,163 | $11.8M | 0.00% | +1,571,120+165.2% | Added |
| Bank of America Corp | 2,656,359 | $12.4M | 0.00% | +297,118+12.6% | Added |
| Silverarc Capital Management, LLC | 3,032,060 | $14.2M | 1.58% | +1,120,275+58.6% | Added |
| Soleus Capital Management, L.P. | 3,377,981 | $15.8M | 0.54% | −425,961−11.2% | Reduced |
| Two Sigma Investments, LP | 3,469,707 | $16.2M | 0.01% | +434,073+14.3% | Added |
| Wasatch Advisors Inc | 3,522,644 | $16.5M | 0.11% | +560,883+18.9% | Added |
| Goldman Sachs Group Inc | 3,530,991 | $16.5M | 0.00% | +1,143,613+47.9% | Added |
| Citadel Advisors LLC | 4,187,580 | $19.6M | 0.01% | +1,676,565+66.8% | Added |
| Vanguard Capital Management LLC | 4,417,731 | $20.6M | 0.00% | +555,879+14.4% | Added |
| JPMorgan Chase & Co | 4,747,424 | $20.7M | 0.00% | +1,524,370+47.3% | Added |
| Bain Capital Life Sciences Investors, LLC | 7,171,910 | $33.5M | 1.99% | 00.0% | Unchanged |
| Squadron Capital Management LLC | 7,200,000 | $33.6M | 11.51% | +4,950,000+220.0% | Added |
| Lynx1 Capital Management LP | 7,326,691 | $34.2M | 3.95% | +327,789+4.7% | Added |
| BlackRock, Inc. | 7,896,718 | $36.9M | 0.00% | +5,848,192+285.5% | Added |
| Ra Capital Management, L.P. | 8,000,000 | $37.4M | 0.32% | 00.0% | Unchanged |
| Morgan Stanley | 8,867,338 | $41.4M | 0.00% | −205,062−2.3% | Reduced |
| Huntington National Bank | 107 | – | – | +107 | New |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −856,353−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Hennion & Walsh Asset Management, Inc. | 0 | $0 | 0.00% | −223,168−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −162,930−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −130,081−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −127,517−100.0% | Sold out |
| Verdad Advisers, LP | 0 | $0 | 0.00% | −109,407−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −92,647−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −59,700−100.0% | Sold out |
| Readystate Asset Management LP | 0 | $0 | 0.00% | −49,586−100.0% | Sold out |
| Colony Group, LLC | 0 | $0 | 0.00% | −38,187−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −34,594−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −28,000−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −26,120−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −25,740−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −23,944−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −23,733−100.0% | Sold out |
| Dauntless Investment Group, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Nine Masts Capital Ltd | 0 | $0 | 0.00% | −14,157−100.0% | Sold out |
| CTC Alternative Strategies, Ltd. | 0 | $0 | 0.00% | −10,792−100.0% | Sold out |
| SummitTX Capital, L.P. | 0 | $0 | 0.00% | −10,466−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −10,203−100.0% | Sold out |
| Ethic Inc. | 0 | $0 | 0.00% | −10,131−100.0% | Sold out |
| Blackston Financial Advisory Group, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −74−100.0% | Sold out |
| Hantz Financial Services, Inc. | 0 | $0 | 0.00% | −3−100.0% | Sold out |